Total Payments
$1.5M
2024 Payments
$197,925
Companies
59
Transactions
2,380
Medicare Patients
630
Medicare Billing
$66,822
Payment Breakdown by Category
Other$1.2M (79.6%)
Travel$143,127 (9.5%)
Consulting$113,399 (7.6%)
Food & Beverage$47,898 (3.2%)
Education$982.48 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.1M | 528 | 75.0% |
| Travel and Lodging | $143,127 | 419 | 9.5% |
| Consulting Fee | $113,399 | 46 | 7.6% |
| Honoraria | $67,680 | 40 | 4.5% |
| Food and Beverage | $47,898 | 1,316 | 3.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,103 | 1 | 0.1% |
| Education | $982.48 | 30 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $617,381 | 621 | $0 (2024) |
| Gilead Sciences, Inc. | $318,490 | 450 | $0 (2024) |
| Janssen Products, LP | $302,766 | 270 | $0 (2023) |
| Theratechnologies Inc. | $92,782 | 128 | $0 (2024) |
| Merck Sharp & Dohme LLC | $79,428 | 247 | $0 (2024) |
| EMD Serono, Inc. | $29,477 | 42 | $0 (2020) |
| ABBVIE INC. | $26,981 | 107 | $0 (2024) |
| Napo Pharmaceuticals Inc | $17,325 | 43 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $4,161 | 21 | $0 (2020) |
| Janssen Scientific Affairs, LLC | $2,216 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $197,925 | 217 | ViiV Healthcare Company ($150,634) |
| 2023 | $180,888 | 256 | ViiV Healthcare Company ($113,732) |
| 2022 | $235,023 | 306 | ViiV Healthcare Company ($122,317) |
| 2021 | $150,089 | 179 | ViiV Healthcare Company ($71,555) |
| 2020 | $175,447 | 213 | ViiV Healthcare Company ($74,042) |
| 2019 | $250,015 | 462 | ViiV Healthcare Company ($68,964) |
| 2018 | $175,753 | 394 | Gilead Sciences, Inc. ($64,095) |
| 2017 | $134,597 | 353 | Gilead Sciences Inc ($46,351) |
All Payment Transactions
2,380 individual payment records from CMS Open Payments — Page 1 of 96
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 12/26/2024 | Gilead Sciences, Inc. | Descovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| Category: HIV | ||||||
| 12/17/2024 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: HIV | ||||||
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $110.28 | General |
| 12/16/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 12/16/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 12/10/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: HIV | ||||||
| 12/09/2024 | Napo Pharmaceuticals Inc | Mytesi (Drug) | Food and Beverage | Cash or cash equivalent | $23.21 | General |
| Category: Infectious Disease | ||||||
| 12/03/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/02/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,925.00 | General |
| Category: HIV | ||||||
| 11/20/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 11/19/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 11/18/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $2,450.00 | General |
| 11/18/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 11/14/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Travel and Lodging | In-kind items and services | $767.22 | General |
| Category: HIV | ||||||
| 11/14/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $114.30 | General |
| Category: HIV | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Education | In-kind items and services | $10.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/07/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Travel and Lodging | In-kind items and services | $1,360.98 | General |
| Category: HIV | ||||||
| 11/07/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Travel and Lodging | In-kind items and services | $232.68 | General |
| Category: HIV | ||||||
| 11/07/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $99.45 | General |
| Category: HIV | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $73.60 | General |
| 10/30/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: HIV | ||||||
| 10/28/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| Category: HIV | ||||||
| 10/24/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $124.50 | General |
| Category: HIV | ||||||
| 10/23/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $344.51 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 73 | 137 | $46,655 | $10,704 |
| 2022 | 2 | 53 | 122 | $45,030 | $9,300 |
| 2021 | 2 | 41 | 62 | $19,830 | $4,719 |
| 2020 | 13 | 463 | 770 | $108,096 | $42,099 |
Total Patients
630
Total Services
1,091
Medicare Billing
$66,822
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 69 | $26,772 | $5,867 | 21.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 18 | $9,282 | $2,312 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 38 | $10,121 | $2,055 | 20.3% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 12 | 12 | $480.00 | $469.68 | 97.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 103 | $39,969 | $8,130 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 19 | $5,060 | $1,170 | 23.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 50 | $17,701 | $4,361 | 24.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 12 | $2,129 | $357.94 | 16.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 112 | 334 | $66,466 | $22,556 | 33.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 77 | 77 | $12,441 | $8,598 | 69.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 61 | 118 | $15,694 | $5,590 | 35.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 17 | 21 | $5,628 | $2,179 | 38.7% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 17 | 17 | $1,915 | $1,026 | 53.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 39 | 40 | $1,720 | $641.52 | 37.3% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 25 | 44 | $1,232 | $423.82 | 34.4% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 15 | 15 | $585.00 | $291.84 | 49.9% |
| 82274 | Stool analysis for blood | Office | 2020 | 14 | 14 | $644.00 | $222.24 | 34.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 11 | 11 | $473.00 | $174.85 | 37.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2020 | 24 | 24 | $336.00 | $148.80 | 44.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 39 | 43 | $602.00 | $129.00 | 21.4% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 12 | 12 | $360.00 | $119.70 | 33.3% |
About Dr. Brian Beesley, DO
Dr. Brian Beesley, DO is a Family Medicine healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447213970.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Beesley, DO has received a total of $1.5M in payments from pharmaceutical and medical device companies, with $197,925 received in 2024. These payments were reported across 2,380 transactions from 59 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.1M).
As a Medicare-enrolled provider, Beesley has provided services to 630 Medicare beneficiaries, totaling 1,091 services with total Medicare billing of $66,822. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Columbus, OH
- Active Since 04/07/2006
- Last Updated 07/23/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1447213970
Products in Payments
- DOVATO (Drug) $283,818
- SYMTUZA (Drug) $152,679
- RUKOBIA (Drug) $117,154
- APRETUDE (Biological) $110,765
- Descovy (Drug) $100,272
- Symtuza (Drug) $67,470
- TROGARZO (Drug) $66,857
- Biktarvy (Drug) $62,406
- Truvada (Drug) $58,343
- PREZCOBIX (Drug) $45,383
- CABENUVA (Biological) $44,198
- SEROSTIM (Biological) $29,089
- DELSTRIGO (Drug) $22,464
- Mavyret (Drug) $21,463
- ISENTRESS (Drug) $20,820
- Epclusa (Drug) $19,427
- Mytesi (Drug) $17,325
- PIFELTRO (Drug) $11,636
- EGRIFTA (Drug) $10,419
- EGRIFTA SV (Drug) $10,149
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Columbus
Dr. Jeffrey Kingsley, D.o, D.O
Family Medicine — Payments: $407,144
Family Medicine $407,144
Dr. Joseph Surber, Do, DO
Family Medicine — Payments: $147,174
Family Medicine $147,174
Bantwal Baliga, Md,Dgo, MD,DGO
Family Medicine — Payments: $124,562
Family Medicine $124,562
Bryan Feldman, D.o, D.O
Family Medicine — Payments: $48,287
Family Medicine $48,287
Elizabeth Martin, M.d, M.D
Family Medicine — Payments: $27,168
Family Medicine $27,168
Dr. Angelice Alexander-Martin, Md, MD
Family Medicine — Payments: $25,386
Family Medicine $25,386